Brooktree Capital Management’s AbbVie ABBV Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $920K | Buy |
4,958
+3,900
| +369% | +$724K | 0.6% | 23 |
|
|
2025
Q1 | $222K | Buy |
+1,058
| New | +$222K | 0.17% | 24 |
|
|
2024
Q4 | – | Sell |
-1,091
| Closed | -$215K | – | 23 |
|
|
2024
Q3 | $215K | Buy |
+1,091
| New | +$215K | 0.18% | 25 |
|
|
2024
Q2 | – | Sell |
-1,130
| Closed | -$206K | – | 24 |
|
|
2024
Q1 | $206K | Sell |
1,130
-3,517
| -76% | -$640K | 0.16% | 24 |
|
|
2023
Q4 | $720K | Sell |
4,647
-106
| -2% | -$16.4K | 0.58% | 24 |
|
|
2023
Q3 | $708K | Hold |
4,753
| – | – | 0.59% | 23 |
|
|
2023
Q2 | $640K | Hold |
4,753
| – | – | 0.49% | 25 |
|
|
2023
Q1 | $757K | Sell |
4,753
-3,742
| -44% | -$596K | 0.59% | 23 |
|
|
2022
Q4 | $1.37M | Sell |
8,495
-1,050
| -11% | -$170K | 1.13% | 19 |
|
|
2022
Q3 | $1.28M | Sell |
9,545
-211
| -2% | -$28.3K | 1.05% | 19 |
|
|
2022
Q2 | $1.49M | Sell |
9,756
-1,816
| -16% | -$278K | 1.12% | 18 |
|
|
2022
Q1 | $1.88M | Sell |
11,572
-3,383
| -23% | -$548K | 1.22% | 21 |
|
|
2021
Q4 | $2.03M | Sell |
14,955
-1,011
| -6% | -$137K | 1.24% | 23 |
|
|
2021
Q3 | $1.72M | Sell |
15,966
-912
| -5% | -$98.4K | 1.1% | 26 |
|
|
2021
Q2 | $1.9M | Sell |
16,878
-73
| -0.4% | -$8.22K | 1.22% | 26 |
|
|
2021
Q1 | $1.83M | Sell |
16,951
-3,745
| -18% | -$405K | 1.23% | 28 |
|
|
2020
Q4 | $2.22M | Sell |
20,696
-277
| -1% | -$29.7K | 1.63% | 22 |
|
|
2020
Q3 | $1.84M | Sell |
20,973
-70
| -0.3% | -$6.13K | 1.55% | 22 |
|
|
2020
Q2 | $2.07M | Buy |
21,043
+1,359
| +7% | +$133K | 1.94% | 20 |
|
|
2020
Q1 | $1.5M | Sell |
19,684
-270
| -1% | -$20.6K | 1.74% | 23 |
|
|
2019
Q4 | $1.77M | Buy |
+19,954
| New | +$1.77M | 1.62% | 25 |
|